Clinical Data, Inc.
Clinical Data, Inc. Reports Third Quarter Fiscal 2010 Results
Published in Cardiovascular Business Week, February 23rd, 2010
Clinical Data, Inc. (NASDAQ: CLDA) announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter. Third Quarter and Recent Highlights Completed a public offering which generated approximately $47.4 million in gross proceeds
Initiated the first Phase III trial of Stedivaze, a potential best-in-class coronary vasodilator for cardiac stress testing
Increased FAMILION® genetic testing gross revenue by 25% and improved gross margins from 35% to 53%, over the same period a year...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- 3SBio Inc.
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil for Hyperphosphatemia - AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Provides Feraheme(R) Safety Update - American Egg Board
Cracking Cholesterol Confusion During American Heart Month - American Heart Association
Age-Related Gaps Closing, Patient Care and Outcomes Improving at Get With the Guidelines-Stroke Hospitals - American Heart Association
American Heart Association Comment on Hospitalization of President Bill Clinton - American Heart Association
American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
